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A B S T R A C T
Simple sequence repeats (SSRs), simple tandem repeats (STRs) or microsatellites are short tandem repeats of 1–6
nucleotide motifs. They are twice as abundant as the protein coding DNA in the human genome and yet little is
known about their functional relevance. Analysis of genomes across various taxa show that despite the instability
associated with longer stretches of repeats, few SSRs with speciﬁc longer repeat lengths are enriched in the
genomes indicating a positive selection. This conserved feature of length dependent enrichment hints at not only
sequence but also length dependent functionality for SSRs. In the present study, we selected 23 SSRs of the
human genome that show speciﬁc repeat length dependent enrichment and analysed their cis-regulatory po-
tential using promoter modulation, boundary and barrier assays. We ﬁnd that the 23 SSR sequences, which are
mostly intergenic and intronic, possess distinct cis-regulatory potential. They modulate minimal promoter ac-
tivity in transient luciferase assays and are capable of functioning as enhancer-blockers and barrier elements.
The results of our functional assays propose cis-gene regulatory roles for these speciﬁc length enriched SSRs and
opens avenues for further investigations.
1. Introduction
Simple sequence repeats (SSRs), also known as microsatellites or
simple tandem repeats (STRs), are short stretches of 1–6 nucleotide
motifs repeated in tandem, with the repetitive unit generally occurring
anywhere between 10 and 20 times. SSRs are present in both verte-
brates and invertebrates and occur throughout the genome, in coding as
well as the non-coding regions. About 3% of the human genome is
comprised of the SSRs, which is almost twice the amount of protein
coding DNA. Depending on the repeat, long stretches of SSRs are highly
unstable once the repeat length threshold of 60–150 bp is reached. This
instability, causing repeat length polymorphisms, is explained by strand
slippage replication and faulty recombination which ultimately con-
tribute to high mutation rates in SSR (~10−2–10−7 per cell division)
(Kim and Mirkin, 2013). Repeat length polymorphisms are signiﬁcant
as they accelerate the rate of evolution of genes and are also useful in
genetic mapping and linkage analysis studies (Moxon et al., 1994; Kashi
and King, 2006). Aberrant expansions of SSRs are cause of nearly thirty
hereditary neurodegenerative and developmental diseases, among
which the triplet repeat expansion disorders are well studied (La Spada
and Taylor, 2010).
Though little is known about the functions of SSRs, studies have
proposed roles for this class of repetitive DNA in regulation of gene
expression, DNA replication and repair, recombination, genome orga-
nisation and evolution (Field and Wills, 1996; Li et al., 2004; Kumar
et al., 2010; Kumar et al., 2013). Genome-wide analysis of SSRs and
gene expression changes in lymphoblastoid cells report that more than
two thousand SSRs within 100 kb of transcriptional start and end sites
of gene transcripts are capable of aﬀecting gene expression. These SSRs
acting as expression quantitative trait loci (eQTLs) are enriched in
conserved regions, regulatory elements and regions marked with cer-
tain epigenetic marks. Few expression STRs (eSTRs) also associated
with clinically relevant conditions (Gymrek et al., 2016). Another study
showed that ˃100 SSRs within± 1 kb of transcription start site of genes
in the HapMap population were associated with changes in expression
(e)/methylation (m) levels of adjacent genes. These eSTRs/mSTRs
overlapped with transcription factor binding and DNaseI hypersensitive
sites (Quilez et al., 2016). It has been suggested that inter-species
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variations not completely explained by single nucleotide polymorph-
isms (SNPs) may be explained by polymorphisms in STR regions, and
more signiﬁcantly by the promoter associated STRs. 25% of protein
coding genes in humans have STRs of ≥3 repeats in their core pro-
moters. A small fraction of these promoters also have longer repeats of
≥6 which are evolutionarily conserved, functionally signiﬁcant and
contribute to variability among organisms (Ohadi et al., 2012).Varia-
tions in lengths of SSRs in promoter regions of Pax3/7 binding protein,
PAXBP1 (CT-repeat), SGB2B2, a member of secretoglobins (CA-repeat)
and cytohyesin-4 (CYTH4) (GTTT-repeat) have been shown to inﬂuence
their gene expression and may have played vital role in evolution of
primate species (Mohammadparast et al., 2014; Rezazadeh et al., 2014;
Nikkhah et al., 2015).
Our previous analysis of abundance of each of 501 theoretically
possible SSRs of diﬀerent repeat unit lengths, across genomes of 24
organisms showed that the SSR abundance generally decreases with
increase in their repetitive units. However, of the 501, 73 SSRs though
following the same trend were additionally and unusually enriched at
speciﬁc repeat lengths in diﬀerent organisms (45 bp was optimally
preferred).We referred to this feature as ‘length preference’. This fea-
ture of preferential length dependent enrichment was conserved across
taxa suggesting that these SSRs have been positively selected for by
nature not only based on their sequence but also repeat lengths
(Ramamoorthy et al., 2014). We hypothesised that these SSRs may have
functional signiﬁcance and maybe involved in gene regulation. In the
present study, we systematically analysed 23 SSRs occurring in the
human genome, which are a subset of the 73 SSRs identiﬁed across
various organisms. These 23 SSRs show speciﬁc length preference and
constitute about half of the total SSRs of the human genome (un-
published data). We analysed these SSRs for cis-regulatory potential
using well established assays in cell lines of human origin. Our results
reveal that many of the 23 SSRs are capable of modulating promoter
activity in transient assays and are also capable of showing boundary
activity.
2. Materials and methods
2.1. SSR oligonucleotides, cell culture and transfection
SSRs were synthesised (Euroﬁns Genomics, Bangalore, India) as
oligonucleotides of speciﬁed lengths (Table 1) and were cloned into
respective assay plasmids by ligation. The following human cell lines
were used in the study: IMR-32 (neuroblastoma cell line), MCF-7
(breast adenocarcinoma cell line), HeLa (cervix adenocarcinoma cell
line), HEK293T (human embryonic kidney cell line) and K562 (ery-
thromyeloblastoidleukemia cell line). Cells were grown in Dulbecco's
Modiﬁed Eagle Medium (DMEM) (Invitrogen) supplemented with 10%
FCS (fetal calf serum) and antibiotics (penicillin, streptomycin and
kanamycin) and were maintained in a humidiﬁed incubator at 37 °C
and 5% CO2. For the assays, lipid mediated transfection was carried out
using Lipofectamine® 2000 (Invitrogen). Brieﬂy, cells were seeded
18–24 h before transfection in 24 or 6-well plates. 400 ng or 1 μg of
DNA was used for transfection and cells were incubated in the DNA-
lipid transfection mix. After 3–4 h the transfection mix was replaced
with fresh medium. Cells were harvested after 24 h for luciferase assays
or transferred to fresh medium containing drugs (G418 or blasticidin)
for drug selection.
2.2. Luciferase assay for modulation of promoter activity
SSRs were cloned in pGL3-promoter vector which contains a SV40
promoter upstream of the luciferase gene. Cells were plated in 24-well
plates 18–24 h before transfection. 200–400 ng of test constructs or
empty vector control were co-transfected with ~10 ng or less of pRL-TK
(Renilla luciferase). Cells were harvested after 24 h of transfection,
washed twice with PBS and lysed using Passive lysis buﬀer (Dual Glo
luciferase assay system, Invitrogen) and the assay was performed ac-
cording to the manufacturer's instructions. Luciferase activity of pRL-TK
was used to normalise transfection eﬃciency. Relative luciferase ac-
tivity was determined by normalising the ratios of ﬁreﬂy to Renilla
luciferase activities of test constructs to that of the empty vector. A
fragment of the mouse HoxD PRE region (mHoxPRE-FI) which modu-
lated promoter activity positively in our previous study was used as a
positive control (Vasanthi et al., 2013). Averages of 3–4 independent
experiments along with their standard errors of mean are expressed.
Statistical signiﬁcance calculated using Student's t-test is shown
(p < 0.05 *,< 0.01 **,< 0.001 ***,< 0.0001 ****).
2.3. Boundary assay
Enhancer blocker or boundary assay was carried out by colony
formation assay using K562 cells as described previously (Chung et al.,
1993). Brieﬂy, vectors were generated each with an SSR oligonucleo-
tide inserted between the mHS2 enhancer and human γ-globin pro-
moter controlling the expression of neomycin resistance gene (neor) in a
slightly modiﬁed form of the parent vector, pJC54. A chicken β-globin
insulator element present downstream of the neomycin resistance gene
protects it from the position eﬀects in the genome. Equal numbers of
K562 cells seeded in 6-well plates were transfected with 5 μg of each
test construct along with 1 μg of vector expressing blasticidin drug re-
sistance gene as a control for transfection. After 24–36 h of transfection,
cells were plated in duplicates in soft agar medium. Number of neo-
mycin-resistant colonies was determined from at least three view-ﬁelds
Table 1
Summary of promoter modulation and boundary assays in K562 cell line.










1 A 36/36 -⁎ - NA
2 AT 21/42 ↓↓ 0.58⁎⁎⁎ √ -
3 AAG 19/57 - - NA
4 AAT 14/42 ↑↑ 2.35⁎⁎ - NA
5 ATC 12/36 ˗ √ -
6 AGAT 10/40 ↑ 1.54⁎⁎ √ -
7 AAAG 13/52 - - NA
8 AAAT 10/40 - √ -
9 AAGG 11/44 ↑↑↑ 2.72⁎⁎⁎ - NA
10 ACAT 10/40 ↑↑↑ 2.91⁎⁎⁎ - NA
11 ATCC 9/36 - - NA
12 AAAAG 11/55 ↑↑↑ 2.73⁎⁎ - NA
13 AAAAT 8/40 ↑↑ 2.34⁎⁎⁎ √ -
14 AAAGG 12/60 ↑↑↑ 3.12⁎⁎⁎ - NA
15 AACAT 10/50 - √ w
16 AAGAG 12/60 ↑↑ 2.12⁎⁎⁎ √ -
17 AAGGG 11/55 ↑ 1.76⁎⁎⁎ - -
18 AATAC 12/60 ↑↑ 2.36⁎⁎⁎ √ -
19 AATAG 11/55 ↓↓ 0.51⁎⁎⁎⁎ - NA
20 AATAT 9/45 ↑↑ 2.05⁎⁎⁎ - NA
21 AATGG 8/40 ↑ 1.63⁎⁎ - -
22 ACATAT 8/48 ↑ 1.95⁎⁎ - NA




Maximally enriched repeat number of the SSRs in the human genome as determined in
the previous study (Ramamoorthy et al., 2014) and their corresponding length in bp are
shown. Promoter modulation and boundary assays in K562 cell line are summarised.
Upward arrows indicate basal promoter activity ≥1.5 fold while lower arrows indicate
promoter activity ≤0.8 fold (↑ 1.5–2, ↑↑ 2–2.5, ↑↑↑ > 2.5, ↓ 0.8–0.6, ↓↓ 0.6–0.4, ↓↓↓
< 0.4-fold). √ - positive boundary activity; ‘-’ no change when compared to control.
a Positive controls used in the assays - mHoxPRE-FI for promoter modulation assay and
β-globin boundary element for boundary assay.
⁎ p < 0.05.
⁎⁎ p < 0.01.
⁎⁎⁎ p < 0.001.
⁎⁎⁎⁎ p < 0.0001.
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in each well. Surviving colonies in G418 medium for each construct
relative to the empty vector, normalised for transfection diﬀerences
(using the number of blasticidin resistant colonies) are represented. β-
Globin boundary element was taken as a positive control. Test con-
structs showing values equal to or below a cut oﬀ of 0.7 were concluded
as possessing boundary activity. Average of results from at least two
independent experiments and their standard errors of mean are shown.
Statistical signiﬁcance calculated using Students t-test is represented
(p < 0.05 *,< 0.01 **,< 0.001 ***,< 0.0001 ****).
2.4. Barrier assay
The vector used for barrier assays, pFSBS was generated by mod-
ifying the vector LMBP4800 (Heyninck and Beyaert, 1999). pFSBS
contains a GFP reporter gene driven by CAGG promoter under control
of a CMV-IE enhancer. A β-globin insulator is cloned upstream of the
enhancer while the test SSRs are cloned in the MCS downstream of the
GFP reporter. The vector also contains a blasticidin drug resistance gene
after the MCS for selection of stable transfectants. K562 cells were used
for this assay. Cells were transfected with vector control or test con-
structs. Stable transfectants were selected for about 2–3 weeks. Fol-
lowing this, drug was withdrawn and disappearance of GFP was mon-
itored by FACS (ﬂuorescence assisted cell sorting) using MoFlo
(DakoCytomation) at regular intervals. Percent GFP positive cells were
normalised to the empty vector control at each time point. A construct
having chicken β-globin insulator elements cloned on either side was
used as a positive control (B3). Results from at least two independent
experiments along with their standard deviations are expressed. Sta-
tistical signiﬁcance is calculated using Students t-test (p < 0.05
*,< 0.01 **,< 0.001 ***,< 0.0001 ****).
3. Results
Our previous analysis of SSRs in 24 organisms across the evolu-
tionary lineage identiﬁed 73 SSRs that showed speciﬁc repeat length
dependent enrichment in the genomes (Ramamoorthy et al., 2014). We
chose to study a subset of the 73 SSRs, speciﬁcally, the 23 SSRs oc-
curring in the human genome. We determined the fraction of the total
SSRs that is constituted by these 23 SSRs in the human genome. Our
bioinformatics analysis revealed that the 23 SSRs showing length pre-
ference make up a major portion (almost 50%) of the SSRs in the human
genome, while the rest of the 478 SSRs, constitute the other 50% (un-
published data). Thus, the 23 SSRs showing length preference are
among the most abundant SSRs in the human genome. The 23 SSRs
include one monomer (A), a dimer (AT) three trimers (AAG, AAT and
ATC), six tetramers (AAAG, AAGG, ACAT, AGAT, AAAT and ATCC), ten
pentamers (AAAAG, AAAGG, AAGGG, AAAAT, AACAT, AAGAG, AAT-
AC, AATAG, AATAT and AATGG) and two hexamers (ACATAT and A-
GATAT). Majority of these SSRs are AT rich. Analysis of their dis-
tribution in the genome revealed that they are mostly in the intronic
and intergenic regions. The optimally preferred repeat length as as-
sessed from their repeat length versus abundance plots was ~45 bp
(Ramamoorthy et al., 2014). Conservation of sequence and repeat
length preferences suggests that these SSRs have functional sig-
niﬁcance. Many reports have suggested a transcriptional regulatory role
for SSRs (Hoﬀman et al., 1990; Lafyatis et al., 1991; Sandaltzopoulos
et al., 1995; Gymrek et al., 2016; Quilez et al., 2016). Hence, we ana-
lysed transcriptional cis-regulatory potential of these 23 SSRs using
well-established promoter modulation, boundary and barrier assays.
For each of the 23 SSRs, the repeat lengths used in the assays corre-
sponded to their optimally preferred repeat lengths in the genome
(Table 1).
The 23 SSRs are mostly intergenic or intronic. We hypothesised that
these repeats are likely to inﬂuence promoter activities rather than act
as promoters themselves. To test this, each of the 23 SSRs was cloned
upstream of the SV40 promoter in pGL3-promoter vector. An increase
or decrease in basal luciferase activity was used as an indicator of
promoter modulating activity. SSRs showing luciferase activity of 1.5-
fold and higher compared to the vector control were considered as
positive modulators of promoter activity, while those showing an ac-
tivity of 0.8-fold and lower were considered as modulating promoter
activity negatively. The assay was performed in ﬁve human cells lines
(IMR-32, MCF7, HeLa, HEK293 and K562) and results obtained in K562
cell line are shown (Fig. 1). Results indicate that all SSRs are capable of
modulating promoter activity in at least one cell line (Supplementary
Table 1). In the K562 cells, SSRs AT and AATAG inﬂuenced promoter
activity negatively while AAG, AAAT, AAGG, AAAAG, AAAAT, AAAGG,
AAGAG, AATAC and AATGG modulated promoter activity positively by
≥2-fold (Fig. 1).In addition to K562, AT and AATAG also decreased
promoter activity while AAAT, AAAAG, AAAGG increased promoter
activity in at least four other cell lines that we tested. Other SSRs in-
cluding AAG, AAGG, AAAAT, AAGAG, AATAC and AATGG modulated
promoter activity in a cell-type speciﬁc manner. For example, AAG,
AAGG, AAAAT, AAGAG, AATAC and AATGG modulated promoter ac-
tivity positively in K562 cells but did not show similar activity in other
cell lines (Supplementary Table 1).
Enhancer-blocker or boundary elements prevent aberrant interac-
tions between unrelated enhancers and promoters. Such elements can
be identiﬁed by an assay based on the principle that when a boundary
element is placed between an enhancer and a promoter driving a re-
porter gene, it can prevent communication between them and thus
decrease the expression of the downstream reporter gene (Chung et al.,
Fig. 1. Promoter modulation assay for the 23 human SSRs in
K562 cell line.
Promoter modulation assay was carried out in K562 cell line.
SSRs were cloned upstream of SV40 promoter which regulates
the luciferase gene. Luciferase activity was determined, nor-
malised to vector control. Statistically signiﬁcant results are re-
presented (p < 0.01 **,< 0.001 ***,< 0.0001 ****).
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1993). SSRs were tested for their ability to abrogate communication
between mHS2 enhancer and γ-globin promoter controlling neomycin
resistance gene in an in vitro assay in K562 cells. Using the β-globin
insulator element as a positive control, boundary assay was carried out.
SSRs AT, ATC, AGAT, AAAT, AAAAT, AACAT, AAGAG and AATAC
showed signiﬁcant boundary activity in this assay (Fig. 2).
Barriers are elements that prevent spreading of heterochromatin
into the euchromatin domains. Many known boundary elements like
the β-globin boundary in mammals and t-DNA in yeast function as both
boundaries and barriers (Chung et al., 1993; Donze et al., 1999). Since
eight SSRs showed boundary function, they were tested for barrier ac-
tivity. The barrier assay is based on the principle that transgenes in the
genome are silenced over a period of time by the gradual spread of
heterochromatin. However, a transgene ﬂanked by barrier elements
should prevent or delay this silencing. Using GFP as a reporter gene the
ability of SSRs showing boundary activity to act as barrier elements was
tested in K562 cell line (Fig. 3). Of the eight SSRs tested, AACAT
showed weak barrier activity while others showed negligible barrier
activity.
4. Discussion
Though simple sequence repeats (SSRs) comprise about 3% of the
human genome, very little is known about their functional relevance.
These tandem repeats of motifs ranging from1–6 bp occur throughout
the genome, both in coding and non-coding regions. Though longer
repeat lengths are quite unstable, few SSRs showing preference for a
speciﬁc optimal repeat length have been positively selected in various
organisms. In order to decipher their functional relevance, the 23 SSRs
of the human genome showing enrichment at speciﬁc repeat lengths
were analysed in this study. The speciﬁc optimal length at which these
SSRs are enriched in the genome was chosen as the length of the test
SSRs in our assay constructs. Hypothesising a cis-regulatory function,
investigations pertaining to the ability of these SSRs to modulate pro-
moter activity and to function as boundary and barrier elements were
carried out. Our results indicate that these 23 SSRs of the human
genome have the potential to act as cis-regulatory elements.
SSR elements have been shown to regulate DNA replication and
repair, recombination and gene expression. SSRs present in the reg-
ulatory regions of genes involved in the cell cycle and genes involved in
correcting replication errors, the DNA MMR genes, inﬂuence their ex-
pression (Chang et al., 2001). SSRs are hotspots for DNA recombina-
tion. Dinucleotide repeats capable of forming stable secondary struc-
tures bind to Rad family of recombination proteins and inﬂuence the
process of recombination (Biet et al., 1999). Signiﬁcant association
between frequency of recombination and the GT repeat in chromosome
22 is found in humans (Majewski and Ott, 2000). SSRs in or near
promoter region of genes inﬂuence their gene expression. The homo-
purine/homopyrimidine tract in heat shock protein, Hsp26
(Sandaltzopoulos et al., 1995), (TCCC)n repeat in promoter of c-KI-ras
and TGF-β3 (Hoﬀman et al., 1990; Lafyatis et al., 1991), (CAG)7 repeat
in 5′ UTR of human calmodulin (hCALM1) gene (Toutenhoofd et al.,
1998), TCAT repeats in the ﬁrst intron of tyrosine hydroxylase gene
(Meloni et al., 1998) and the (CA)n tract in ﬁrst intron of epidermal
growth factor receptor (EGFR) gene (Gebhardt et al., 1999) inﬂuence
the activities of their corresponding promoters. Not only repeat motifs
but also repeat lengths inﬂuence SSR function. Frequency of RecA de-
pendent homologous recombination in vitro decreases with increase in
repeat length of GT SSR (Dutreix, 1997). Transcriptional activity of
EGFR gene declines with increasing number of CA repeats (Gebhardt
et al., 1999). Pax6 gene promoter activity in human brain is 8–10 fold
higher for the> 29 repeat variant of (AC)m (AG)n when compared to its
26-repeat variant (Okladnova et al., 1998). SSRs also serve as binding
sites for regulatory proteins. Many proteins/protein complexes from
nuclear extracts of cells have been shown to bind SSRs in vitro (Aharoni
et al., 1993; Epplen et al., 1993). Interestingly, SSR repeat numbers also
inﬂuence protein binding (Solomon et al., 1986; Winter and
Varshavsky, 1989). SSRs inﬂuence epigenetic regulation of genes. DNA
methylation is observed at CCG repeat associated loci where the CCG
repeat secondary structures serve as excellent substrates for DNA me-
thyltransferases (Smith et al., 1994). The CCG repeat expansion of FXS
allele is associated with increased H3K9me2 (Pietrobono et al., 2005)
while AAG repeat has been found to be associated with silent histone
modiﬁcation marks (Greene et al., 2007; Al-Mahdawi et al., 2008). The
GATA repeat functions as an enhancer blocker in Drosophila and human
cells (Kumar et al., 2013) while AAGAG is essential for Drosophila
Fig. 2. Boundary assay for the 23 human SSRs in K562 cell line.
SSRs were cloned between the mHS2 enhancer and human γ-globin promoter controlling
the expression of neomycin resistance gene in pJC54 vector. Numbers of neomycin re-
sistant colonies were determined and normalised to vector control. Test constructs
showing values equal to or below a cut oﬀ of 0.7 were considered as possessing boundary
activity (p < 0.05 *).
Fig. 3. Barrier assay in K562 cell line.
Barrier assay was carried out with select boundary positive SSRs in K562 cell line. GFP
levels of stable transfectants were monitored by FACS at regular intervals following drug
withdrawal. Relative GFP levels with their standard deviations at each time point are
represented (p < 0.01 **,< 0.001 ***).
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development and its transcripts are found to be associated with the
nuclear matrix (Pathak et al., 2013). More recently, a genome-wide
analysis of SSRs and gene expression changes in lymphoblastoid cells
showed that more than two thousand SSRs within 100 kb of tran-
scriptional start and end sites of gene transcripts are capable of af-
fecting gene expression (Gymrek et al., 2016).
Given the various reports on the gene regulatory potential of SSRs,
we sought to analyse if the 23 SSRs of the human genome, each
showing speciﬁc length preference, have cis-regulatory potential. The
23 SSRs were intronic or intergenic and were not found very close to the
transcription start sites of genes. We therefore hypothesised that these
repeats were more likely to inﬂuence (enhance or repress) promoter
activities rather than act as promoters themselves. The promoter
modulating activity of the SSRs was assessed by their ability to increase
or decrease the activity of a minimal promoter driving luciferase gene.
Though transient assays may not be a true reﬂection of the SSR function
in genomic context, this assay still has the advantage of exposing the
minimal cis-regulatory activity associated with these DNA sequences.
The promoter luciferase assay showed that almost all of the 23 SSRs
possess cis-regulatory activity in at least one cell line (Supplementary
Table 1). Some SSRs exclusively modulated promoter activity positively
or negatively in more than one cell line while others did so in a cell-type
speciﬁc manner. Eight of the SSRs were found to be positive for
boundary activity in our boundary assay with 23 SSRs. We correlated
promoter modulation assay and boundary assay carried out in the same
cell line, K562. We observed that SSRs AAAT, AAAAT, AAGAG and
AATAC which were positive for boundary activity also modulated
promoter activity negatively, suggesting that these may be repressor
elements rather than boundary elements. A, ATC, AGAT and AACAT did
not alter promoter luciferase activity but were positive for boundary
activity, suggesting that these are likely to be true boundary elements.
Few other SSRs positive for boundary activity increased promoter ac-
tivity in the luciferase assay. Though this is intriguing, it may be pos-
sible that the SSR elements may function to maintain an open chro-
matin structure and/or recruit DNA binding proteins which may
facilitate transcription as previously reported (Soeller et al., 1993).
However, further analysis would conﬁrm if these SSRs indeed are true
boundary elements. Few other SSRs decreased promoter activity of the
SV40 promoter (promoter modulation assay) but not the γ-globin pro-
moter (boundary assay) suggesting that SSRs may function not only in a
cell-type speciﬁc but also in a promoter speciﬁc manner. Some of the
established boundary elements like the β-globin boundary in mammals
and t-DNA in yeast also function as barriers. Hence, we carried out
barrier assay for the boundary positive SSRs. We analysed a population
of stable transfectants to alleviate any bias arising due to insertions at
active/inactive genomic loci which might lead to clonal variations in
our observations. Results of the barrier assay indicated that most of the
tested SSRs show negligible barrier activity albeit for one, AACAT,
which seemed to show weak barrier activity in our study.
Thus, our analysis postulates a cis-regulatory potential for the 23
SSRs of the human genome that show speciﬁc length preference. To our
knowledge this is the ﬁrst study that systematically analyses 23 SSRs of
the human genome occurring in intergenic and intronic regions for
their biological function and opens avenues for further investigations.
Our results suggest minimal and cell-type speciﬁc cis-regulatory po-
tential for these DNA repeat sequences. However, it is of great interest
and importance to study the functions of these SSRs and the relevance
of their repeat lengths in their native genomic location and chromatin
contexts. Most of these SSRs have been found to occur in nucleosome
free regions (unpublished data), suggesting that they may have speciﬁc
roles in regulation of DNA replication and transcription. It is also very
likely that these SSRs have roles in genome organisation, alternative
splicing, modulation of chromatin structure and transcription of non-
coding RNAs. Discovery and analysis of speciﬁc proteins binding to
these SSRs is also likely to provide valuable insights into their functions.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.gene.2017.07.022.
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